{"version":"1.0","type":"link","title":"CRISPR/Cas9 library screening uncovered CCT2 as a critical driver of acquired resistance to EGFR-targeted therapy by stabilizing TMX1 in non-small cell lung cancer.","author_name":"Ke Z 외","author_url":"https://prs-insight.online/author/Ke%20Z","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/94987","thumbnail_width":1200,"thumbnail_height":630}